Grupo Cryo

What Grupo Cryo does

Grupo Cryo is a privately held, for-profit medical services company headquartered in Naucalpan de Juárez, Mexico, that specializes in the diagnosis and treatment of cancer. Operating under the web domain crioablacion.com, the company's nomenclature indicates a clinical focus on cryoablation, a minimally invasive technique that uses extreme cold to destroy tumor tissue across a range of oncologic indications. Founded in 2006, the firm maintains a clinical workforce of 51–100 employees, consistent with a single-site or small multi-site specialty practice serving patient referrals.

The company's core offering is procedural: diagnostic evaluation of cancer cases followed by image-guided cryoablation treatment. As a private services business in a regulated clinical environment, revenue mechanics are tied to procedure volumes, payer mix (private pay, insurance, public-sector referrals in Mexico), and pricing per case. The company does not disclose pricing models, contract structures, or revenue figures in the available source material.

The available source data is thin on operating detail. The corporate website returned only a verification/loading page during data collection, and no management team, funding history, certifications, partnerships, office locations, named customers, or specific product/service catalog entries are documented. Investment-relevant operational intelligence — beyond the firm's basic profile (Mexican oncology services, founded 2006, 51–100 staff, private) — is therefore limited, and readers should treat any inferences as low-confidence.

Name

Grupo Cryo

Website

https://crioablacion.com

Company type

Private

Founded year

2006

Headcount range

51–100 employees

Short description

Grupo Cryo is a privately held Mexican oncology services provider, founded in 2006 and based in Naucalpan de Juárez, that specializes in the diagnosis and treatment of cancer, with its domain indicating a focus on cryoablation procedures, serving patients and referring physicians through a 51–100-employee clinical practice.

Ownership category

akta.pro rank

Product category

Oncology Services

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cryotherapy Services (HSADAKAE)

Keywords

• Cancer treatment services
• Oncology services
• Cryoablation therapy
• Cancer diagnostics
• Medical oncology

Headquarters

HQ city

Naucalpan De Juárez

HQ country

Mexico

HQ region

Latin America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Core offering

Grupo Cryo specializes in the diagnosis and treatment of cancer diseases. The company's domain (crioablacion.com) indicates the use of cryoablation techniques — a procedure that uses extreme cold to destroy cancerous tissue — as part of its oncology service offering. Operations are based in Naucalpan de Juárez, Mexico.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Diagnosis and Treatment Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights3 records

Regional players

• Centro Médico ABC: Centro Médico ABC is a leading private hospital in Mexico City with an established oncology center serving similar high-income and insured patient segments as Grupo Cryo. Comparable as a regional peer for cancer diagnosis and treatment in the same metro, though operating as a general tertiary hospital rather than a cryotherapy specialist.
• Hospital Angeles: Hospital Angeles is one of Mexico's largest private hospital networks, providing multi-specialty cancer care in the same Mexico City metro area where Grupo Cryo operates. Comparable as a regional peer competing for the same privately insured and self-pay oncology patients, but offering a broader portfolio rather than a cryotherapy-specialized niche.

Direct peers

• AngioDynamics: AngioDynamics produces cryoablation and irreversible electroporation (NanoKnife) platforms for solid tumor treatment, directly addressing the same oncology indications (prostate, kidney, liver, lung) that Grupo Cryo treats. Comparable as a competing technology and service-enablement player in cryoablation-based cancer care.
• Galil Medical (a BTG / Boston Scientific brand): Galil Medical, now part of Boston Scientific, historically specialized in cryoablation systems for kidney, prostate, and other urologic/oncologic tumors. Comparable to Grupo Cryo as a long-standing cryoablation-focused oncology brand on the technology side of the same value chain.
• HealthTronics: HealthTronics is a US-based provider of cryoablation and other minimally invasive therapies for urological and oncologic conditions, operating both as a service provider and equipment partner. It is the closest analogue to Grupo Cryo's model of delivering cryoablation cancer treatment as a service in a clinic setting.

Broad incumbents

• Medtronic: Through its legacy Covidien portfolio, Medtronic offers cryoablation and related ablation technologies used in oncology and other specialties. Comparable to Grupo Cryo as a broad incumbent that influences pricing, training, and technology access for cryoablation in cancer care.
• Boston Scientific: Boston Scientific manufactures the Visual-ICE and other cryoablation systems used in oncology and urology, and through its acquisition of Galil Medical is one of the leading vendors of cryoablation technology. Comparable to Grupo Cryo as the dominant equipment-side counterparty in the cryoablation oncology ecosystem it participates in.

Emerging players

• IceCure Medical: IceCure Medical develops cryoablation systems (ProSense) primarily for breast, kidney, and other cancers, and has been pushing minimally invasive cryotherapy into outpatient settings globally. Comparable to Grupo Cryo as a focused, cryotherapy-first oncology player, though on the device side rather than the clinical service side.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/grupocryo
• Facebookfacebook.com/GrupoCryo
• LinkedInlinkedin.com/company/grupo-cryo

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Cryo